ACACA and hepatocellular carcinoma: Furthermore, small-molecule therapies that mimic ACC phosphorylation, such as ND-654 and ND-646, have been shown to prevent and treat hepatocellular carcinoma in rat models and to prevent non-small-cell lung cancer development in human cells and in mice (Lally et al., 2019; Svensson et al., 2016).